Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report) was the recipient of a large increase in short interest in September. As of September 30th, there was short interest totalling 145,800 shares, an increase of 34.5% from the September 15th total of 108,400 shares. Approximately 0.6% of the company’s shares are short sold. Based on an […]
Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report) and Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership. Volatility and Risk Unicycive Therapeutics has a […]